Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$122.22
-0.5%
$122.12
$107.43
$150.57
$5.35B0.841.59 million shs1.51 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
+1.32%-1.46%-0.30%-10.35%-9.45%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
2.71
Moderate Buy$122.15N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/A23.96N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$0.380.31%N/AN/AN/A

Latest IBB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/17/2025
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$0.12123/18/20253/18/20253/21/2025
(Data available from 1/1/2013 forward)

Institutional Ownership

CompanyInstitutional Ownership
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
62.45%

Insider Ownership

CompanyInsider Ownership
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/A43.75 millionN/AOptionable

Recent News About These Companies

Key Stock Market ETFs, Bitcoin Creating A Story
Top-rated biotechs with negative enterprise values
Can Health Care ETFs Aid Your Portfolio?

New MarketBeat Followers Over Time

Media Sentiment Over Time

iShares Biotechnology ETF stock logo

iShares Biotechnology ETF NASDAQ:IBB

$122.22 -0.63 (-0.51%)
As of 03:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.